PMID- 36544115 OWN - NLM STAT- MEDLINE DCOM- 20221223 LR - 20221224 IS - 1472-6823 (Electronic) IS - 1472-6823 (Linking) VI - 22 IP - 1 DP - 2022 Dec 21 TI - The non-linear link between remnant cholesterol and diabetic retinopathy: a cross-sectional study in patients with type 2 diabetic mellitus. PG - 326 LID - 10.1186/s12902-022-01239-5 [doi] LID - 326 AB - OBJECTIVE: Research on residual cholesterol (RC) and diabetic retinopathy (DR) remains limited. As a result, the current study was designed to investigate the relationship between RC and DR in patients with type 2 diabetic mellitus (T2DM). METHODS: This cross-sectional study consecutively and non-selectively collected a total of 1964 type 2 diabetic mellitus patients in two hospitals in Taiwan from April 2002 to November 2004. A binary logistic regression model was then used to assess the independent relationship between RC level and DR and proliferative diabetic retinopathy (PDR). A generalized additive model (GAM) and smooth curve fitting were used to investigate the actual shape of the curve between them. It was stated that the data had been uploaded to the website: https://journals.plos.org/plosone . RESULTS: The average age of the participants was 64.10+/- 11.32 years old, with 42.92% being male. The prevalence of DR and PDR was 35.13 and 18.13%, respectively. The mean RC level was 30.57 +/- 14.60 mg/dL. We found no significant association between RC and DR (OR = 1.001; 95% CI 0.991, 1.011) or PDR (OR = 1.008; 95% CI 0.995, 1.021) based on a fully adjusted logistic regression model. Results remained robust across a series of sensitivity analyses. However, a non-linear relationship was detected between RC and DR. Using a two-piece logistic regression model and a recursive algorithm, we found an inflection point of RC was 13.0 mg/dL. A 1-unit increase in the RC level was associated with 19.4% greater adjusted odds of DR (OR = 1.194; 95% CI 1.070, 1.333) when RC < 13.0 mg/dL. There was also a non-linear relationship between RC and PDR, and the inflection point of the RC was 39.0 mg/dL. When RC < 39.0 mg/dL, a 1-unit increase in the RC level was associated with 2.1% greater adjusted odds of PDR (OR = 1.021; 95% CI 1.004, 1.038). CONCLUSION: This study demonstrates a non-linear relationship between RC and DR or PDR in type 2 diabetic mellitus patients. Our findings provide new insights into advancing research on the link between RC and DR or PDR. CI - (c) 2022. The Author(s). FAU - Pan, Wushan AU - Pan W AD - Department of Nephrology, Kaifeng Central Hospital, Kaifeng, 475000, Henan Province, China. FAU - Han, Yong AU - Han Y AD - Department of Emergency, Shenzhen Second People's Hospital, Guangdong Province, Shenzhen, 518000, China. AD - Department of Emergency, The First Affiliated Hospital of Shenzhen University, Guangdong Province, Shenzhen, 518000, China. FAU - Hu, Haofei AU - Hu H AD - Department of Nephrology, Shenzhen Second People's Hospital, Guangdong Province, Shenzhen, 518000, China. huhaofei0319@126.com. AD - Department of Nephrology, The First Affiliated Hospital of Shenzhen University, Guangdong Province, Shenzhen, 518000, China. huhaofei0319@126.com. FAU - He, Yongcheng AU - He Y AD - Department of Nephrology, Shenzhen Hengsheng Hospital, No.3002 Sungang Road, Futian District, Shenzhen, 518000, Guangdong Province, China. heyongcheng640815@126.com. LA - eng PT - Journal Article DEP - 20221221 PL - England TA - BMC Endocr Disord JT - BMC endocrine disorders JID - 101088676 SB - IM MH - Humans MH - Male MH - Middle Aged MH - Aged MH - Female MH - *Diabetic Retinopathy/epidemiology/etiology MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Cross-Sectional Studies MH - Prevalence MH - Logistic Models PMC - PMC9768989 OTO - NOTNLM OT - Cross-sectional study OT - Diabetic retinopathy OT - Generalized additive model OT - Non-linear OT - Proliferative diabetic retinopathy OT - Remnant cholesterol COIS- The authors declare that they have no competing interests EDAT- 2022/12/22 06:00 MHDA- 2022/12/24 06:00 PMCR- 2022/12/21 CRDT- 2022/12/21 23:43 PHST- 2022/04/06 00:00 [received] PHST- 2022/12/06 00:00 [accepted] PHST- 2022/12/21 23:43 [entrez] PHST- 2022/12/22 06:00 [pubmed] PHST- 2022/12/24 06:00 [medline] PHST- 2022/12/21 00:00 [pmc-release] AID - 10.1186/s12902-022-01239-5 [pii] AID - 1239 [pii] AID - 10.1186/s12902-022-01239-5 [doi] PST - epublish SO - BMC Endocr Disord. 2022 Dec 21;22(1):326. doi: 10.1186/s12902-022-01239-5.